Gilead Sciences to Release First Quarter 2021 Financial Results on Thursday, April 29, 2021
Gilead Sciences, Inc. (Nasdaq: GILD) will release its first quarter 2021 financial results on April 29, after market close. A conference call is scheduled for 4:30 p.m. Eastern Time the same day to discuss these results and provide a business update. Investors can access the live webcast through Gilead's Investors page or by dialing in with provided numbers. The webcast will be available for one year on Gilead's website. The company focuses on innovative medicines for life-threatening diseases, operating in over 35 countries worldwide.
- Scheduled release of Q1 2021 results may indicate positive growth trends.
- Conference call provides an opportunity for stakeholders to gain insights into business developments.
- None.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2021 financial results will be released on Thursday, April 29, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s first quarter 2021 financial results and will provide a business update.
A live webcast of the call can be accessed at Gilead’s Investors page at http://investors.gilead.com, or by dialing 1-877-359-9508 (U.S.) or 1-224-357-2393 (international) with conference ID 5069935. The webcast will be archived on www.gilead.com for one year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210415005950/en/
FAQ
When will Gilead Sciences release its Q1 2021 financial results?
What time is Gilead's conference call for Q1 2021 results?
How can I access Gilead Sciences' conference call?